𝐖𝐞 𝐚𝐫𝐞 𝐝𝐞𝐥𝐢𝐠𝐡𝐭𝐞𝐝 𝐭𝐨 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐨𝐮𝐫 𝐫𝐞𝐥𝐚𝐭𝐢𝐨𝐧𝐬𝐡𝐢𝐩 𝐰𝐢𝐭𝐡 𝐓𝐚𝐤𝐞𝐝𝐚 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐥𝐚𝐬𝐦𝐚 𝐃𝐞𝐫𝐢𝐯𝐞𝐝-𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐚𝐫𝐞𝐚 𝐩𝐨𝐬𝐭 𝐩𝐨𝐬𝐢𝐭𝐢𝐯𝐞 𝐢𝐧 𝐯𝐢𝐭𝐫𝐨 𝐭𝐞𝐬𝐭𝐬. 🗨 “Direct nanoforming of biologics is a promising new approach to allow more life-changing large-molecule medicines to reach the market,” commented Dr. Edward Haeggström, CEO of Nanoform. “We look forward to entering in vivo studies together with Takeda and expanding our already very positive relationship.” For full details please see the Press Release 👉 https://lnkd.in/eWkqSat8 #nanoparticles #drugdelivery #plasmaderivedtherapies #biologics #nanomedicine
Congratulations! Always happy to see a new collaboration between innovative leaders!
Senior Vice President at PharmaVentures - Biopharma early development and deal stage commercial & access strategy consulting.
2moCongratulations!!🥂 fantastic news!